PTEN and glioblastoma: Mesenchymal GBM typically contains gene mutations in the phosphatase and tensin homolog (PTEN), TP53, and NF1, and exhibits a highly immune suppressive microenvironment, strong invasiveness, and treatment resistance compared to other subtypes [10].